昂利康：获得布比卡因化学原料药上市申请批准通知书

Core Insights - The company Anglikon (002940) has received approval from the National Medical Products Administration for the marketing application of Bupivacaine [1] Group 1 - Bupivacaine is primarily used in clinical settings for local anesthesia and postoperative analgesia [1]